BD MAX STAPHSR ASSAY, INSTRUMENT

System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)

The following data is part of a premarket notification filed by Geneohm Sciences Canada, Inc. (bd Diagnostics) with the FDA for Bd Max Staphsr Assay, Instrument.

Pre-market Notification Details

Device IDK132822
510k NumberK132822
Device Name:BD MAX STAPHSR ASSAY, INSTRUMENT
ClassificationSystem, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Applicant GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) 2555 Boul. Du Parc-Technologique Quebec,  CA G1p 4s5
ContactPatricia Dionne
CorrespondentPatricia Dionne
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) 2555 Boul. Du Parc-Technologique Quebec,  CA G1p 4s5
Product CodeNQX  
CFR Regulation Number866.1640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-09-09
Decision Date2013-11-26
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00382904434199 K132822 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.